valproic acid has been researched along with Xanthomatosis, Cerebrotendinous in 1 studies
Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.
Xanthomatosis, Cerebrotendinous: An autosomal recessive lipid storage disorder due to mutation of the gene CYP27A1 encoding a CHOLESTANETRIOL 26-MONOOXYGENASE. It is characterized by large deposits of CHOLESTEROL and CHOLESTANOL in various tissues resulting in xanthomatous swelling of tendons, early CATARACT, and progressive neurological symptoms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cerebrotendinous xanthomatosis is one of the rare forms of treatable hereditary neurodegenerative disorders." | 1.35 | Cerebrotendinous xanthomatosis: a treatable neurodegenerative disease. ( Jayakrishnan, C; Sadanan, S; Sandeep, P; Sreekumar, S; Thulasidharan, NK, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sandeep, P | 1 |
| Jayakrishnan, C | 1 |
| Sadanan, S | 1 |
| Sreekumar, S | 1 |
| Thulasidharan, NK | 1 |
1 other study available for valproic acid and Xanthomatosis, Cerebrotendinous
| Article | Year |
|---|---|
Cerebrotendinous xanthomatosis: a treatable neurodegenerative disease.
Topics: Adult; Anticonvulsants; Carbamazepine; Chenodeoxycholic Acid; GABA Agents; Gastrointestinal Agents; | 2009 |